Pablo Lavados MD, MPH

Pablo Lavados, MD, MPH, is a professor of Neurology at Universidad del Desarrollo. Dr. Lavados is a clinician and researcher at the Vascular Neurology Unit in Clínica Alemana, as well as the director of the Research and Clinical Trials Unit at Clínica Alemana in Santiago. He earned his medical degree and completed postgraduate training in Neurology at Universidad de Chile. He obtained a master’s degree in Public Health at Johns Hopkins University School of Public Health, Baltimore, Maryland. He also completed a clinical research fellowship at La Sapienza, University in Rome, Italy, as well as a Postdoctoral Clinical Research Fellowship in Cerebrovascular Diseases at Johns Hopkins University School of Medicine.

Dr. Lavados was the principal investigator of the PISCIS epidemiological stroke Project and is the country leader of three international academic clinical trials: INTERACT2, ENCHANTED, and HEADPOST MAIN, organized by The George Institute for Global Health of Australia, and the principal co-investigator of the HEADPOST PILOT clinical trial and the RECCA stroke registry in Clínica Alemana, and co-investigator in the OPTIC Stroke Registry, the SOCRATES, and NAVIGATE ESUS international clinical trials, as well as the recently published ÑANDU stroke surveillance study in southern Chile. He is also a co-investigator in the ADDSPISE clinical trial. He has been awarded the Presidential Scholarship, a PAHO scholarship, and a Fulbright scholarship, among other awards. He is also a Ministry of Health advisor on the national stroke program in Chile.

Dr. Lavados is currently the president of the Chilean Stroke Association (ACEVE) and vice president of the Iberoamerican Stroke Society (SIECV). In his research, Dr. Lavados focuses primarily on the epidemiology of cerebrovascular disease and clinical trials in stroke. He has authored more than 150 papers in peer-reviewed journals and has lectured around the globe on topics that include: Quality control in stroke care, organized stroke care, secondary prevention of stroke, epidemiology of stroke, thrombolysis in acute ischemic stroke, and research in stroke.